Expert: results of an exit JOINT-STOCK COMPANY "ROSNANO" from "Nanolek" - an example of system effectiveness of state support

Show original
The director of RNC Pharma Rasshchupkin Pawel considers that this transaction will have positive impact on investment climate to Russian Federation...
Analysis
×
Mikhail Nekrasov
Main activity:Official
Andrey Reus
Last position: Chairman of the board of directors (LLC "MBTS "Generium")
Anatoly Chubais
Last position: Member of Presidium (ARVE)
3
Rasshchupkin Pawel
Novartis Int AG
Main activity:Health care and social services
10
JSC Rusnano
Main activity:Communication and IT
11
LLC "Nanolek"
Main activity:Science and education
3
Nanolek Holding Ltd
Organizations
Merck KGaA
Main activity:Health care and social services
9